0000950159-05-000028.txt : 20120703 0000950159-05-000028.hdr.sgml : 20120703 20050118164118 ACCESSION NUMBER: 0000950159-05-000028 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050118 DATE AS OF CHANGE: 20050118 GROUP MEMBERS: A. ANDY NAHAS GROUP MEMBERS: PROSPECT MANAGEMENT, LLC FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PROSPECT FUND LP CENTRAL INDEX KEY: 0000933286 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 250 MILL STREET CITY: ROCHESTER STATE: NY ZIP: 14614 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40150 FILM NUMBER: 05534138 BUSINESS ADDRESS: STREET 1: 211 SOMERVILLE ROAD STREET 2: ROUTE 202 NORTH CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 9084702800 MAIL ADDRESS: STREET 1: 211 SOMERVILLE ROAD STREET 2: ROUTE 202 NORTH CITY: BEDMINSTER STATE: NJ ZIP: 07921 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 SC 13G/A 1 kmz13g.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) (Amendment No. )* Bioject Medical Technologies Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------------------------------- (Title of Class of Securities) 09059T206 -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2004 -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section ================================================================================ CUSIP No. 09059T206 13G/A --------- -------------------------------------------------------------------------------- (1) NAMES OR REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS A. Andy Nahas -------------------------------------------------------------------------------- (2) CHECK APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) [ ] (b) [X] -------------------------------------------------------------------------------- (3) SEC USE ONLY -------------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------------- (5) SOLE VOTING POWER 0 --------------------------------------------------- (6) SHARED VOTING POWER 469,611 --------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING (7) SOLE DISPOSITIVE POWER 0 PERSON WITH --------------------------------------------------- (8) SHARED DISPOSITIVE POWER 469,611 --------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 469,611 -------------------------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] -------------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.4% -------------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN -------------------------------------------------------------------------------- * ================================================================================ CUSIP No. 09059T206 13G/A --------- -------------------------------------------------------------------------------- (1) NAMES OR REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS The Prospect Fund, L.P. -------------------------------------------------------------------------------- (2) CHECK APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) [ ] (b) [X] -------------------------------------------------------------------------------- (3) SEC USE ONLY -------------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------------- (5) SOLE VOTING POWER 0 ----------------------------------------------- (6) SHARED VOTING POWER NUMBER OF SHARES 469,611 BENEFICIALLY OWNED ----------------------------------------------- BY EACH REPORTING PERSON WITH (7) SOLE DISPOSITIVE POWER 0 ----------------------------------------------- (8) SHARED DISPOSITIVE POWER 469,611 -------------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 469,611 -------------------------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] -------------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.4% -------------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN -------------------------------------------------------------------------------- ================================================================================ CUSIP No. 09059T206 13G/A --------- -------------------------------------------------------------------------------- (1) NAMES OR REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Prospect Management, LLC -------------------------------------------------------------------------------- (2) CHECK APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) [ ] (b) [X] -------------------------------------------------------------------------------- (3) SEC USE ONLY -------------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------------- (5) SOLE VOTING POWER 0 --------------------------------------------------- (6) SHARED VOTING POWER NUMBER OF SHARES 469,611 BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH --------------------------------------------------- (7) SOLE DISPOSITIVE POWER 0 --------------------------------------------------- (8) SHARED DISPOSITIVE POWER 469,611 --------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 469,611 -------------------------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] -------------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.4% -------------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO -------------------------------------------------------------------------------- Item 1. (a) Name of Issuer. Bioject Medical Technologies Inc. (b) Address of Issuer's Principal Executive Offices. 211 Somerville Road, Route 202 North Bedminister, NJ 07921 Item 2. (a) Name of Persons Filing. This Schedule 13G Amendment is being filed with respect to shares of Common Stock of the Issuer which are beneficially owned by A. Andy Nahas, The Prospect Fund, L.P. and Prospect Management, LLC (collectively, the "Reporting Persons"). (b) Address of Principal Business Office or, if none, Residence. The principal business address of each of the Reporting Persons is: 250 Mill Street, Suite 105 Rochester, New York 14614 (c) Citizenship. Mr. Nahas is a United States Citizen. Each of The Prospect Fund, L.P. and Prospect Management, LLC is organized in New York. (d) Title of Class of Securities. Common Stock (e) CUSIP Number. 09059T206 Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act. (d) [ ] Investment Company registered under Section 8 of the Investment Company Act. (e) [ ] Investment Adviser in accordance with Sec. 240.13d-1(b)(1)(ii)(E). (f) [ ] Employee Benefit Plan or Endowment Fund in accordance with Sec. 240.13d-1(b)(1)(ii)(F). (g) [ ] Parent holding company, in accordance with Sec. 240.13d-1(b)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940. (j) [ ] Group, in accordance with Sec. 240.13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Sec. 240.13d-1(c), check this box [ x ]. Item 4. Ownership A. Mr. Nahas (a) Amount Beneficially Owned. 469,611 (b) Percent of Class. 3.4% (c) Number of shares as to which each such person has (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: 469,611 (iii) sole power to dispose or to direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 469,611 As calculated in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended, A. Andy Nahas beneficially owns 469,611 shares of the Issuer's Common Stock ("Common Stock"), representing 3.4% of the Common Stock. Mr. Nahas does not directly own any shares of Common Stock, but he indirectly owns 469,611 shares of Common Stock in his capacity as the sole manager and sole member of Prospect Management, LLC, a New York limited liability company which serves as the general partner for The Prospect Fund, L.P., a New York Limited Partnership. B. Prospect Management, LLC (a) Amount beneficially owned: 469,611 (b) Percent of Class: 3.4% (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: 0 (ii) Shared power to vote or to direct the vote: 469,611 (iii)Sole power to dispose or direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 469,611 As calculated in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended, Prospect Management, LLC ("Prospect Management"), a New York limited liability company, beneficially owns 469,611 shares of the Issuer's Common Stock ("Common Stock"), representing 3.4% of the Common Stock. Prospect Management does not directly own any shares of Common Stock, but it indirectly owns 469,611 shares of Common Stock in its capacity as the general partner for The Prospect Fund, L.P., a New York limited partnership. C. The Prospect Fund, L.P. (a) Amount beneficially owned: 469,611 (b) Percent of Class: 3.4% (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: 0 (ii) Shared power to vote or to direct the vote: 469,611 (iii)Sole power to dispose or direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 469,611 As calculated in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended, The Prospect Fund, L.P. a New York limited partnership, beneficially owns 469,611 shares of the Issuer's Common Stock ("Common Stock"), representing 3.4% of the Common Stock.
Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X] Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 18, 2005 THE PROSPECT FUND, L.P. By: Prospect Management, LLC, its general partner By: /s/ A. Andy Nahas --------------------------- Name: A. Andy Nahas Title: Manager PROSPECT MANAGEMENT, LLC By: /s/ A. Andy Nahas --------------------------- Name: A. Andy Nahas Title: Manager A. ANDY NAHAS By: /s/ A. Andy Nahas --------------------------- Name: A. Andy Nahas Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13G The undersigned hereby agree jointly to prepare and file with regulatory authorities a Schedule 13G and any amendments thereto reporting each of the undersigned's ownership of securities of Bioject Medical Technologies Inc. and hereby affirm that such Schedule 13G is being filed on behalf of each of the undersigned. Date: January 18, 2005 /s/ A. Andy Nahas -------------------------------- Name: A. Andy Nahas THE PROSPECT FUND, L.P. By: Prospect Management, LLC, its general partner By: /s/ A. Andy Nahas -------------------------------- Name: A. Andy Nahas Title: Manager PROSPECT MANAGEMENT, LLC By: /s/ A. Andy Nahas -------------------------------- Name: A. Andy Nahas Title: Manager